Combined Inhibition of Dipeptidyl Peptidase IV (DPIV/CD26) and Aminopeptidase N (APN/CD13) in the Treatment of Psoriasis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00824980
Recruitment Status : Unknown
Verified January 2009 by Immune Technologies & Medicine GmbH.
Recruitment status was:  Recruiting
First Posted : January 19, 2009
Last Update Posted : January 19, 2009
Information provided by:
Immune Technologies & Medicine GmbH

No Study Results Posted on for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : September 2009
  Estimated Study Completion Date : September 2009